Amedisys Inc Revenue per Employee (AMED), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amedisys Inc  (NASDAQ: AMED)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Amedisys Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5.19% in the second quarter 2025, year on year to cumulative value of $2,402 million, Amedisys Inc's revenue per employee grew on a trailing twelve months basis to $ 126,440, this marks a new company high.
Within the Healthcare sector Employees of 395 other companies have achieved higher revenue per employee. While Amedisys Inc's total ranking has deteriorated compared to the previous quarter from 2898 to 2925. Amedisys Inc has 19,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMED Revenue per Employee (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Revenue Change 5.19 % 4.09 % 4.78 % 5.65 % 6.91 %
Sales per Employee (TTM) $ 126,440 124,826 123,596 122,161 120,507
AMED's Total Ranking # 2925 # 2898 # 3234 # 2372 # 241
Seq. Revenue Change 4.55 % -0.55 % 1.77 % -0.59 % 3.46 %

AMED Company Profile >> Back to AMED Efficiency Comparisons >> Compare AMED Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 22
Healthcare Sector # 396
Overall Market # 2925

Revenue per Employee Statistics
High Average Low
$ 126,440 $ 95,686 $ 63,032
(Jun 30 2025)   (Sep. 30, 2014)



Financial Statements
Amedisys Inc's Revenue MRQ $ 622 Millions Visit AMED's Income Statement
Amedisys Inc's Revenues TTM $ 2,402 Millions Visit AMED's aggregate revenue growth
What are AMED's Sales? Visit AMED's Sales by Segment




Other Ratios
Amedisys Inc's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AMED's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AMED's Competitors
Revenue per Employee for AMED's Suppliers
Revenue per Employee for AMED's Customers

You may also want to know
AMED's Sales Growth Rates AMED's Pe Price to earnings ratio AMED's Receivables Turnover Ratio AMED's Stock Quote
AMED's Net Income Growth Rates AMED's Ps Price to Sales ratio AMED's Sales per Employee AMED's Asset Turnover Ratio
AMED's Net Margin AMED's Pb Price to Book ratio AMED's Financial Strength Ratios AMED's Dividend Payout Ratio
Date modified: 2026-06-22T14:32:45+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Marpai Inc  221,242.99 $ 23.673  Million 107 
Nuwellis Inc   216,842.11 $ 8.240  Million 38 
Surgery Partners Inc   215,800.00 $ 3,237.000  Million 15,000 
Pacific Health Care Organization Inc  214,289.03 $ 6.643  Million 31 
Envista Holdings Corporation  212,641.67 $ 2,551.700  Million 12,000 
60 Degrees Pharmaceuticals Inc   210,357.33 $ 0.631  Million 3 
Tenet Healthcare Corp  208,969.70 $ 20,688.000  Million 99,000 
Utah Medical Products Inc  208,158.47 $ 38.093  Million 183 
Myomo Inc   206,269.69 $ 40.223  Million 195 
Zomedica Corp   205,524.82 $ 28.979  Million 141 
Charles River Laboratories International inc   204,498.22 $ 4,028.615  Million 19,700 
Warby Parker Inc   203,315.66 $ 820.582  Million 4,036 
Immutep Limited  202,575.94 $ 10.331  Million 51 
Qhslab Inc   201,760.92 $ 2.421  Million 12 
Fonar Corporation  200,675.61 $ 104.351  Million 520 
Sage Therapeutics Inc   199,461.76 $ 70.410  Million 353 
Xilio Therapeutics Inc   197,381.58 $ 15.001  Million 76 
Teleflex Incorporated  196,168.45 $ 3,040.611  Million 15,500 
Align Technology inc   195,413.50 $ 3,964.940  Million 20,290 
Clearpoint Neuro Inc   195,308.14 $ 33.593  Million 172 
Nuo Therapeutics Inc   195,040.60 $ 1.950  Million 10 
Verrica Pharmaceuticals Inc   193,473.68 $ 14.704  Million 76 
Labcorp Holdings Inc   192,625.71 $ 13,483.800  Million 70,000 
Fortrea Holdings Inc   191,153.85 $ 2,733.500  Million 14,300 
Merit Medical Systems Inc  191,070.00 $ 1,433.025  Million 7,500 
Plus Therapeutics Inc   189,892.86 $ 5.317  Million 28 
Crispr Therapeutics Ag  189,303.48 $ 38.050  Million 201 
Kymera Therapeutics Inc   187,861.34 $ 44.711  Million 238 
Retractable Technologies Inc  187,109.25 $ 37.609  Million 201 
Novartis Ag  186,682.08 $ 14,051.000  Million 75,267 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.